R&D Systems™ Recombinant Human IL-37/IL-1F7 Protein

Catalog No.
92-25I-L025CF	Recombinant Human IL-37/IL-1F7 Protein, Carrier-Free

Catalog No. 92-25I-L025CF Supplier R&D Systems™ Supplier No. 9225IL025/CF

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility.

The Recombinant Human IL-37/IL-1F7 Protein is derived from E. coli. The Recombinant Human IL-37/IL-1F7 Protein has been validated for the following applications: Bioactivity.

Order Info

The product is shipped at ambient temperature.

Specifications

• Accession Number: Q9NZH6-2
• For Use With (Application): Bioactivity
• Formulation: Lyophilized from a 0.2μm filtered solution in PBS and DTT.
• Gene ID (Entrez): 27178
• Molecular Weight (g/mol): 21 kDa
• Name: FIL1, FIL1 zeta, FIL1(ZETA), FIL1ZFIL1 zeta, IL-1F7, IL-1F7IL-1 zeta, IL1H4IL1F7 (canonical product IL-1F7b), IL-1H4IL-1F7b (IL-1H4, IL-1H, IL-1RP1), IL-1RP1IL-1X protein, IL1RP1interleukin 1 family member 7, IL-1X, IL37, interleukin 1 family, member 7 (z
• Quantity: 25μg
• Source: E. coli-derived human IL-37/IL-1F7 protein Ser2-Asp192
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70° C as supplied. 1 month, 2 to 8° C under sterile conditions after reconstitution. 3 months, -20 to -70° C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.10 EU per 1μg of protein by LAL method
• Biological Activity: Measured by its ability to inhibit LPS-stimulated IL-8 secretion by HK-2 human kidney epithelial cells. The ED50 for this effect is 0.25-1.25 μg/mL.
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Purity or Quality Grade: >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie Blue Staining.

For Research Use Only